Urs Fischer becomes new ESO president
Urs Fischer Urs Fischer (Inselspital Bern, Bern, Switzerland) has taken over the presidency of the European Stroke Organisation…
Roche Receives CE Mark for Alzheimer’s Disease Blood Test
Roche received the CE mark for its Elecsys pTau217 blood test, an assay designed to detect Alzheimer’s disease…
Evaluation of cerebral blood flow and glymphatic function in acute mountain sickness by MRI ASL and DTI ALPS
This prospective study was approved by the Medical Ethics Committee of the Affiliated Hospital of Qinghai University, and…
Roche ENSPRYNG cuts MOGAD relapse risk 68%
Roche (OTCQX: RHHBY) reported Phase III METEOROID results showing ENSPRYNG (satralizumab) reduced risk…
Roche Receives CE Mark for Multiple Sclerosis Blood Test
Roche has received the CE mark for its Elecsys Neurofilament Light Chain (NfL) for the detection of neuroinflammation…
Association of reduced DTI-ALPS index and increased free water with glymphatic system alterations in noise-induced hearing loss: a neuroimaging study
Subjects According to the national standard of the People’s Republic of China, GBZ 49-2014 “Diagnosis of Occupational Noise…
Recursion, Roche Unveil Microglia Map of Neuro Disease Targets
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI)…
Roche bids to broaden MS pipeline and strengthen Ocrevus influence
Data presented at ECTRIMS indicate that Roche’s Ocrevus has sustained benefit over two years and potential in expanded…
Novartis returns to alpha-synuclein with $2.2bn Arrowhead deal
Novartis will gain the exclusive worldwide licence to research, develop, manufacture, and commercialise Arrowhead’s siRNA therapy ARO-SNCA. Credit:…
Data builds on Roche’s dominance in primary progressive MS
Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in…